
Glioblastoma multiforme market to grow 13.2% CAGR by 2036 with new therapies advancing.
The glioblastoma multiforme market is projected to grow at a 13.2% CAGR from 2026 to 2036, driven by promising late-stage therapies from companies like Avita Biomedical and Laminar Pharma. The market size was $900 million in 2025, with the US as the ...

